| Outcome Measures: |
Primary: Peak concentration (Cmax), Pharmacokinetic of mitiglinide, 1 day|Time to reach peak concentration (Tmax), Pharmacokinetic of mitiglinide, 1day|Area under plasma concentration -time curve from time zero to time of last quantifiable concentration (AUC0-t), Pharmacokinetic of mitiglinide, 1 day|Area under the plasma concentration-time curve from time zero to infinity of mitiglinide, Pharmacokinetic of mitiglinide, 1 day|The elimination rate constant, Pharmacokinetic of mitiglinide, 1 day|Volume of distribution (Vd/F), Pharmacokinetic of mitiglinide, 1 day|Terminal elimination half-life (T1/2), Pharmacokinetic of mitiglinide, 1 day|Total body clearance (CL/F), Pharmacokinetic of mitiglinide, 1 day|Ratio of AUC0-t to AUC0-infinity, Pharmacokinetic of mitiglinide, 1 day|Area under the blood glucose concentration-time curve from time zero to time of last blood sample (AUC0-t,GLU), Pharmacokinetic of mitiglinide, 1 day|Area under the blood glucose concentration(change from baseline)-time curve from time zero to time of last blood sample (ΔAUC0-t,GLU), Pharmacokinetic of mitiglinide, 1 day|Blood glucose concentration change from baseline at 2 hours after drug administration, Pharmacokinetic of mitiglinide, 1 day |
|
